Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 9
Original Research
The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,552 | Dovepress* | 10,535+ | 2,144 | 12,679 | |
PubMed Central* | 2,017 | 428 | 2,445 | ||
Totals | 12,552 | 2,572 | 15,124 | ||
*Since 24 February 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar